Investments
8Portfolio Exits
3Funds
3
Want to inform investors similar to Franklin Street Equity Partners about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Franklin Street Equity Partners Investments
8 Investments
Franklin Street Equity Partners has made 8 investments. Their latest investment was in Biolex Therapeutics as part of their Series D - II on October 10, 2010.
Franklin Street Equity Partners Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
10/7/2010 | Series D - II | Biolex Therapeutics | $20M | No | Academy Funds, Clarus, Dogwood Equity, Dow Venture Capital, Easton Capital, Franklin Street Equity Partners, InterSouth Partners, Investor Growth Capital, Johnson & Johnson Innovation, Kitty Hawk Capital, Mitsui & Co. Global Investment, OrbiMed Advisors, Polaris Partners, Quaker BioVentures, Tall Oaks Capital, The Trelys Funds, Village Ventures, and Wakefield Group | |
8/15/2003 | Series A | |||||
5/24/2002 | PIPE | |||||
5/4/2001 | PIPE - II | |||||
10/9/2000 | Series B |
Date | 10/7/2010 | 8/15/2003 | 5/24/2002 | 5/4/2001 | 10/9/2000 |
|---|---|---|---|---|---|
Round | Series D - II | Series A | PIPE | PIPE - II | Series B |
Company | Biolex Therapeutics | ||||
Amount | $20M | ||||
New? | No | ||||
Co-Investors | Academy Funds, Clarus, Dogwood Equity, Dow Venture Capital, Easton Capital, Franklin Street Equity Partners, InterSouth Partners, Investor Growth Capital, Johnson & Johnson Innovation, Kitty Hawk Capital, Mitsui & Co. Global Investment, OrbiMed Advisors, Polaris Partners, Quaker BioVentures, Tall Oaks Capital, The Trelys Funds, Village Ventures, and Wakefield Group | ||||
Sources |
Franklin Street Equity Partners Portfolio Exits
3 Portfolio Exits
Franklin Street Equity Partners has 3 portfolio exits. Their latest portfolio exit was Salix Pharmaceuticals on April 01, 2015.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
4/1/2015 | Acq - P2P | 1 | |||
Date | 4/1/2015 | ||
|---|---|---|---|
Exit | Acq - P2P | ||
Companies | |||
Valuation | |||
Acquirer | |||
Sources | 1 |
Franklin Street Equity Partners Acquisitions
1 Acquisition
Franklin Street Equity Partners acquired 1 company. Their latest acquisition was Zelenka Nursery on October 20, 2003.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
10/20/2003 | Acquired |
Date | 10/20/2003 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired |
Sources |
Franklin Street Equity Partners Fund History
3 Fund Histories
Franklin Street Equity Partners has 3 funds, including Capital Gains Opportunity Fund LLC.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
6/1/2019 | Capital Gains Opportunity Fund LLC | REAL Estate | Open | $30M | 1 |
1/2/2004 | Franklin Street Equity Fund II LP | ||||
6/28/1998 | Franklin Street Equity Fund LP |
Closing Date | 6/1/2019 | 1/2/2004 | 6/28/1998 |
|---|---|---|---|
Fund | Capital Gains Opportunity Fund LLC | Franklin Street Equity Fund II LP | Franklin Street Equity Fund LP |
Fund Type | REAL Estate | ||
Status | Open | ||
Amount | $30M | ||
Sources | 1 |
Franklin Street Equity Partners Team
1 Team Member
Franklin Street Equity Partners has 1 team member, including current General Partner, Thomas S Ablum.
Name | Work History | Title | Status |
|---|---|---|---|
Thomas S Ablum | General Partner | Current |
Name | Thomas S Ablum |
|---|---|
Work History | |
Title | General Partner |
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.